[go: up one dir, main page]

0% found this document useful (0 votes)
31 views22 pages

Understanding Infertility Causes and Treatments

A common condition affecting both men and women

Uploaded by

OPIO SAM
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
31 views22 pages

Understanding Infertility Causes and Treatments

A common condition affecting both men and women

Uploaded by

OPIO SAM
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd

INFERTILITY

• INFERTILITY-FAILURE TO CONCEIVE WITHIN 1/MORE YRS OF REGULAR UNPROTECTED


INTERCOURSE
• CAN BE PRY/SEC
• FECUNDABILITY IS THE PROBABILITY OF ACHIEVING A PREGNANCY EACH MONTH (~0.22/MO).
• FECUNDITY IS THE ABILITY TO ACHIEVE A LIVE BIRTH WITHIN 1 MENSTRUAL CYCLE ( ~0.15-
0.18/MO).
EPIDEMIOLOGY
• AFFECTS 10-15% OF COUPLES OR 1 IN 6 COUPLES OF
CHILDBEARING AGE.
• 60% HEALTHY WOMEN UP TO 25 YOA ACHIEVE PREGNANCY
WITHIN 6 MONTHS OF TRYING.
80% OF COUPLES ACHIEVE PREGNANCY WITHIN 1 YEAR OF
TRYING.
MORE COMMON IN DEVELOPING COUNTRIES.
TAKES 2/3 OF CONSULTATION TO GYNAECOLOGIST IN AFRICA.
FACTORS ESSENTIAL FOR CONCEPTION

• HEALTHY SPERMS
• CAPACITATION/ACROSOMEREACTION
• MOTILE SPERMS
• OVULATION
• PATENT FALLOPIAN TUBES
• FERTILISATION
• EMBRYO TOREACH UTERINE CAVITY BY 3-4DYS OF FERTILIZATION
• RECEPTIVE ENDOMETRIUM
AETIOLOGY
MALE FACTORS – 18.8%
FEMALE FACTORS – 32%
MALE AND FEMALE FACTORS COMBINED – 18.5%
UNEXPLAINED AFTER INVESTIGATION – 11.1%
OTHER CAUSES – 5.6%
MALE INFERTILITY CAUSES

• DEFECTIVE SPERMATOGENESIS
• OBSTRUCTION OF EFFERENT DUCT SYSTEM
• FAILURE TO DEPOSIT SPERM HIGH UP IN THE VAGINA
• ERRORS IN SEMINAL FLUID
MALE FACTORS
1. INADEQUATE OR ABNORMAL PRODUCTION OF SPERM
• CONGENITAL E.G. CRYPTORCHIDISM
• TRAUMA, E.G. SPORTS INJURY, VASECTOMY, TORSION
• VARICOCELE
• INFECTION - USUALLY MUMPS ORCHITIS
• RARE: MALIGNANT DISEASE, ENDOCRINEDISEASE,
EXERCISE (OLIGOSPERMIA - LONG DISTANCE RUNNERS)
INADEQUATE PRODUCTION CONT’D
• ENVIRONMENTAL FACTORS – SMOKING REDUCES SPERMATOGENESIS AND TESTICULAR
SIZE; ALCOHOL REDUCES TESTOSTERONE AND SPERM CONCENTRATION;
CANNABINOIDS REDUCE SPERM COUNT AND QUALITY.
• EXCESSIVE RADIATION, HEAVY METALS- LEAD, PESTICIDES, EXPOSURE TO HIGH TEMPS.
• DRUGS – ANTI-CANCER, CIMETIDINE, SPIRONOLACTONE, KETOCONAZOLE, ANABOLIC
STEROIDS, ANTIHYPERTENSIVES, ANTIDEPRESSANTS
MALE FACTORS II
• 2. DEPOSITION PROBLEMS
• BILATERAL OBSTRUCTION OF EPIDIDYMIS OR DUCTS
• EJACULATORY DYSFUNCTION, E.G. RETROGRADE EJACULATION
• ERECTILE DYSFUNCTION
• ABNORMAL POSITION OF URETHRAL ORIFICE
FEMALE INFERTILITY CAUSES

• OVARIAN FACTORS-ANOVULATION, CORPUS LUTEUM INSUFFICIENCY


• TUBAL FACTORS-INFECTIONS/PID, TUBAL LIGATION, ADHESIONS
• UTERINE FACTORS-UNRECEPTIVE ENDOMETRIUM,CHRONIC
ENDOMETRITIS,FIBROID,SYNECHIAE
CONGENITAL MALFORMATION
• CERVICAL FACTORS-CHRONIC CERVICITIS,IMMUNOLOGICAL
FACTORS(ANTISPERM ANTIBODIES)
• PELVIC FACTORS-ENDOMETRIOSIS, ADHESIONS
FEMALE FACTORS I
1. OVULATORY DYSFUNCTION (15-20%)
• HYPERPROLACTINEMIA (E.G. PITUITARY MICROADENOMA)
• POLYCYSTIC OVARIAN DISEASE
• DRUGS (E.G. CIMETIDINE, PSYCHOTROPIC)
• SYSTEMIC DISEASES E.G. THYROID, HEPATO-RENAL
DISEASE, CUSHING SYNDROME, DM
• CONGENITAL - TURNER SYNDROME, TESTICULAR FEMINIZATION,
GONADAL DYSGENESIS, AND GONADOTROPIN DEFICIENCY
• LUTEAL PHASE DEFECT (LPD)
• EXCESSIVE EXERCISE (EVEN IN ABSENCE OF AMENORRHEA) INDUCES
ENDORPHINS - SUPPRESS FSH & LH - LPD
• PREMATURE OVARIAN FAILURE - AUTOIMMUNE DISEASES
HISTORY
• FEMALE; MENSTRUAL HX, PAST GYN HX, H/O PELVIC INFXN,
RUBELLA STATUS, WEIGHT, GEN STATE OF HEALTH &
NUTRITION, IF MENSES IRREGULAR H/O PCOS, ENDOCRINE
DISORDERS, COC HX, DX & RX OF INFERTILITY, OB HX

• MALE; H/O SEXUAL FXN, ERECTION, EJACULATION, ANY H/O


ORCHITIS/VENEREAL DZ, NATURE OF JOB, ABSENCE FROM
HOME, CHRONIC ILL HEALTH.

• BOTH; FREQUENCY OF INTERCOURSE, PENETRATION?,


DISCOMFORT, MALE SATISFACTION?,
CLINICAL EXAMINATION
• FEMALE; GEN. EXAM (ENDOCRINE ABNORMALITIES) & ROUTINE PELVIC EXAM

• MALE; ASSESS SIZE & CONSISTENCY OF TESTES & EPIDYDYMIS, VARICOCELE/HERNIA,


SIZE OF PROSTATE
DIAGNOSIS / INVESTIGATION
OVULATION TESTS
• BASAL BODY TEMPERATURE (BIPHASIC)
• MUCOUS QUALITY (MID-CYCLE)
• ENDOMETRIAL BIOPSY (D&C) 4 LUTEAL PHASE DEFECT (DAY
24-26)
• SERUM PROGESTERONE LEVEL (DAY 20-22); >20NMOL/L
=OVULATION
• SERUM PROLACTIN, TSH, LH, FSH
• IF HIRSUTE (PCOS): SERUM FREE TESTOSTERONE, DHEAS
• OVULATION PREDICTOR KITS
• U/S SCAN DETECTS FOLLICULAR GROWTH & OVULATION
TESTS FOR TUBAL PATENCY
• HYSTEROSALPINGOGRAM, DAY 8-10 = DIAGNOSTIC AND THERAPEUTIC (I.E. MAY OPEN
TUBE JUST PRIOR TO OVULATION)
• LAPAROSCOPY INJECTION OF TUBES WITH DYE
CERVICAL TESTS
• POST-COITAL TEST (DAY 12-14, SPERM MOTILITY IN CERVICAL MUCOUS 2-6 HOURS
AFTER INTERCOURSE)
INVESTIGATIONS CONT’D
• UTERINE TESTS
• HYSTEROSALPINGOGRAM
• HYSTEROSONOGRAM
• HYSTEROSCOPY
REASSURE THE COUPLE THAT COMPLETE INFERTILITY
EVALUATION IS PERFORMED ACCORDING TO THE WOMAN’S
MENSTRUAL CYCLE & MAY TAKE UP TO 2 CYCLES UNTIL THE
CAUSE IS FOUND.
MALE INVESTIGATIONS
• SEMEN ANALYSIS – SAMPLE COLLECTED AFTER 3-5DAYS OF
ABSTINENCE (SPERMATOGENESIS TAKES 72HOURS)
 VOL – 2-5ML
 PH – 7.2-7.8
 SPERM CONCENTRATION – 20MILLION OR GREATER
 MOTILITY – 50%, FORWARD PROGRESSION
 MORPHOLOGY – NORMAL SPERM 50% OR GREATER
 LEUCOCYTES - <1MILLION CELLS/MICROLITRE
TREATMENT
• WATCHFUL WAITING AND TIMED INTERCOURSE – AFTER 3YR 60% WILL CONCEIVE
SPONTANEOUSLY; AFTER 5YR 80%
• EXPECTANT THERAPY FOR 6-12MO IF WOMAN <35YR WITH 2YR OF INFERTILITY
• AGGRESSIVE THERAPY IF >35YR OR >3YR OF INFERTILITY
TREATMENT
MEDICAL
• BROMOCRIPTINE IF INCREASED PROLACTIN
• CLOMIPHENE CITRATE (CLOMID)- CORRECTS FOLLICULAR DVLPT & LPD,
INCREASES NO. OF FOLLICLES + OOCYTES
• HUMAN MENOPAUSAL GONADOTROPIN (PERGONAL) FOR OVULATION
INDUCTION
• UROFOLLITROPIN (FSH) (METRODIN)
• FOLLOWED BY ẞHCG FOR STIMULATION OF OVUM RELEASE
LETROZOLE- ORAL, REVERSIBLE NON-STEROIDAL AROMATASE INHIBITOR
WHICH RELEASES THE ESTROGEN NEG. FEEDBACK, INCR. GNTR,
STIMULATING FOLLICLE DVLPT & INCR. FOLLICLE SENSITIVITY TO FSH SO IS
EFFECTIVE IN INCR. FOLLICLE RECRUITMENT IN UNEXPLAINED INFERTILITY.
PREVENTION & RX OF STI’S & PID + OTHER UNDERLYING MEDICAL
CONDITIONS E.G. DM, HYPERTHYROIDISM, OBESITY/ UNDERWEIGHT.
TREATMENT
SURGICAL
• TUBOPLASTY – SALPINGOLYSIS, SALPINGOSTOMY,
SALPINGOTOMY, VASOSTOMY, MICROSURGERY
• ARTIFICIAL INSEMINATION (HETEROLOGOUS/THERAPEUTIC
INSEMINATION) - DONOR OR HUSBAND
• SPERM WASHING
• IN VITRO FERTILIZATION (IVF)- OVARIAN STIMULATION,
FOLLICULAR ASPIRATION, OOCYTE CLASSFN, SPERM
PREPARATION, OOCYTE INSEMINATION, EMBRYO CULTURE,
EMBRYO TRANSFER.
• GIFT (GAMETE INTRAFALLOPIAN TRANSFER)
• ICSI (INTRACELLULAR SPERM INJECTION)
ZIFT (ZYGOTE INTRAFALLOPIAN TUBE TRANSFER = GIFT+IVF)
COUNSELLING
• OFTEN DIFFICULT CZ OF THE INTIMATE NATURE
OF THE PROBLEM
• NOT ONLY A MEDICAL PROBLEM, BUT ALSO
AFFECTS HER ATTITUDE TO LIFE AND MARRIAGE
• DISPEL IN ANY IDEA THAT THE POSITION IS
HELPLESS
• EXPLAIN THE INVESTIGATIONS AND RESULTS
• DISCUSS THE OPTIONS
• INFERTILITY REGARDED TRADITIONALLY AS
“FAULT” IN THE FEMALE SO HARDER WHEN THE
PROBLEM IS FROM THE MALE.
SOCIAL EFFECTS OF INFERTILITY
STRESS
SOCIAL STIGMA-FEMALES BEAR MOST OF IT(INADEQUATE IN
SOCIETY)
PAIN-NEUROLOGICAL FORMS
ANXIETY/DEPRESSION
DIVORCE OR EXTRAMARITAL STATUS WITH COMPLICATIONS
EXPENSIVE,ETC.

You might also like